Oppenheimer Inc. (OPY) Stock Price, Quote & News

AI Score

Unlock

AI Score

Our AI model analyzes fundamental, technical, and statistical indicators to predict the probability of a bullish trend over the next three months.

We regularly update and refine our models to deliver the most reliable forecasts for you.

Bullish Probability	Sentiment	Score
+80%	Strong Buy	10
+75%	Buy	9
+70%	Buy	8
+60%	Buy	7
+50%	Hold	6
+45%	Hold	5
+40%	Hold	4
+35%	Sell	3
+30%	Sell	2
+20%	Strong Sell	1

Oppenheimer Inc. (OPY)

AI Score

Unlock

AI Score

Bullish Probability	Sentiment	Score
+80%	Strong Buy	10
+75%	Buy	9
+70%	Buy	8
+60%	Buy	7
+50%	Hold	6
+45%	Hold	5
+40%	Hold	4
+35%	Sell	3
+30%	Sell	2
+20%	Strong Sell	1

63.58

0.54 (0.86%)

At close: Jan 14, 2025, 3:59 PM

64.25

1.06%

Pre-market Jan 15, 2025, 08:38 AM EST

undefined% (undefined)

Bid	61.01
Market Cap	650.48M
Revenue (ttm)	-
Net Income (ttm)	-
EPS (ttm)	6.42
PE Ratio (ttm)	9.9
Forward PE	n/a
Analyst	n/a

Ask	65.44
Volume	14,661
Avg. Volume (20D)	31,181
Open	63.50
Previous Close	63.04
Day's Range	62.58 - 63.58
52-Week Range	36.93 - 70.25
Beta	undefined

About OPY

Oppenheimer Holdings Inc., through its subsidiaries, operates as a middle-market investment bank and full-service broker-dealer in the Americas, Europe, the Middle East, and Asia. The company offers brokerage services covering exchange-traded and over-the-counter corporate equity and debt securities, money market instruments, exchange-traded options and futures contracts, municipal bonds, mutual funds, exchange-traded funds, and unit investment t...

[Show more]

Industry Financial - Capital Markets

Sector Financial Services

IPO Date Oct 6, 1982

Employees 2,951

Stock Exchange NYSE

Ticker Symbol OPY

Website https://www.oppenheimer.com

Why Price Moved

2 months ago · Source

+11.44%

Oppenheimer Holdings shares are trading higher aft... Unlock content with Pro Subscription

News

1 week ago · investopedia.com

Shake Shack, Darden, Yum! 'Top Picks' for 2025 Says Oppenheimer

Olive Garden, KFC, and Shake Shack look like particularly appetizing investments in 2025, according to Oppenheimer analysts.

1 week ago · 247wallst.com

Oppenheimer Thinks the Stock Market Will Surge 20% in 2025. 1 Stock To Buy Before it Does

It's a new year, and with that, the 2025 S&P 500 forecasts from the big names on Wall Street are in.

3 weeks ago · https://thefly.com

Roper Technologies assumed with an Outperform at Oppenheimer

Oppenheimer analyst Ken Wong assumed coverage of Roper Technologies with an Outperform rating and $630 price target. The firm sees potential for revenue acceleration with management targeting companie...

3 weeks ago · youtube.com

Oppenheimer's Brian Nagel on Nike: The brand is still in tact

Brian Nagel, Oppenheimer senior analyst, joins 'Closing Bell: Overtime' to discuss Nike earnings and his outlook for the stock.

1 month ago · businesswire.com

McGrath to Participate in the Oppenheimer Midwest Virtual Summit

LIVERMORE, Calif.--(BUSINESS WIRE)--McGrath RentCorp (“McGrath” or the “Company”) (Nasdaq: MGRC), a leading business-to-business rental company in North America, today announced that Joe Hanna, Chief ...

1 month ago · youtube.com

Positive from Lululemon earnings is 'things did not get worse', says Oppenheimer's Brian Nagel

Brian Nagel, Oppenheimer senior equity research analyst, joins 'Closing Bell Overtime' to talk Lululemon quarterly results.

1 month ago · businesswire.com

Satellos to Participate in Oppenheimer Movers in Rare Disease Summit

TORONTO--(BUSINESS WIRE)--Satellos Bioscience Inc. (TSX:MSCL, OTCQB:MSCLF) (“Satellos”), a public biotech company developing new small molecule therapeutic approaches to improve the treatment of muscl...

2 months ago · youtube.com

Oppenheimer's Brian Nagel on Home Depot Q3 results: Largely a weather-driven sales upside

Brian Nagel, Oppenheimer senior analyst, joins 'Squawk Box' to break down Home Depot's Q3 earnings results.

2 months ago · https://thefly.com

Vor Bio price target lowered to $8 from $10 at Oppenheimer

Oppenheimer analyst Matthew Biegler lowered the firm's price target on Vor Bio to $8 from $10 and keeps an Outperform rating on the shares following the Q3 report. The firm cites updated spending esti...

2 months ago · youtube.com

Call of the Day: Oppenheimer raises bank targets

The Investment Committee debate the big bank names.

2 months ago · seekingalpha.com

Oppenheimer Holdings: Mid-Market Prevailing In Capital Markets, Solid All Around

Oppenheimer's earnings report show strength in mid-market capital markets franchise as well as solid growth in the rest of its AUM and commission based businesses. Risk taking in public markets has dr...